Anti-cancer clinical compound library - SAB

Catalog No.	Package Size	Price	Quantity
L2120	100ul*10mM	inquiry

Datasheet Images Protocol

Description

Product NameAnti-cancer clinical compound library
Brief DescriptionDuring the past decades, we have witnessed many landmark discoveries and successes in cancer research and therapy,however, cancer is still a major health problem for human beings, and it often physically and emotionally brings pains and difficulties to those living with it. Cancer cells remain undifferentiated (continue to divide, causing more damage, and invading new tissue), lack normal cell signaling responses (loss of contact inhibition and evasion of programmed cell death), contain abnormal changes (genetic abnormalities) in chromatin, have altered energy metabolism, and induce vascularization (ensure a steady supply of oxygen and nutrients). We carefully select 560 anti-cancer compounds currently in clinical trial phases based on published literatures and database to form this collection that can be used for high throughput screening and high content screening.
Storage Powder or pre-dissolved DMSO solutions in 96 well plate with optional 2D barcodeShipped with blue ice; Stable for One year as powder, 6 months at - 20 ˚ C in DMSO or 12months at -80 ˚ C in DMSO

Application Details

Product Description

Please let us know if you have published research using #L2120 so that we can cite your reference.

No comment

Anti-cancer clinical compound library #L2120